SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-063094
Filing Date
2024-05-17
Accepted
2024-05-17 17:15:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2414843d1_defa14a.htm DEFA14A 17091
2 GRAPHIC tm2414843d1_img001.jpg GRAPHIC 6478
  Complete submission text file 0001104659-24-063094.txt   27536
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36860 | Film No.: 24961309
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)